Introduction {#Sec1}
============

While relative consensus exists about the treatment of femoral neck fractures for elderly patients, the optimal treatment for per- and intertrochanteric fractures is still under debate \[[@CR1], [@CR7]\]. In a previous study of 1,173 patients with proximal femoral fractures it appeared that trochanteric fractures are still a challenge, as 1-year mortality risk and complication rate were considerably higher compared with femoral neck fractures \[[@CR7]\]. As restoration of the preoperative ambulatory level correlated with survival rate after 1 year \[[@CR7]\] and elderly patients are often unable to cooperate with partial weight bearing, the primary stability of the device is crucial to allow early mobilization to prevent cardio-pulmonal complications and thrombosis. Excessive collapse of the fracture site and varus displacement is a common problem of sliding hip screws combined with plates or femoral nails especially in elderly women who often suffer from osteoporosis and poor bone quality \[[@CR16]\]. Therefore, primary arthroplasty was proposed by some authors \[[@CR4], [@CR10], [@CR28]\] but their patient collectives ranging from 37 to 54 were to small to allow general recommendations. Because we used hip arthroplasty even for trochanteric fractures for a long time as a standard procedure \[[@CR7], [@CR26]\], we are now able to report on our experiences in a large number of patients.

This study compares the mortality risks and 1-year postoperative complications between arthroplasty and osteosynthetic fixation (DHS or PFN) for intertrochanteric fractures. A 1-year mortality was chosen as a main indicator as it depends on the surgical trauma as well as the rapid return to preinjury activity and further complications. A 1-year period was chosen as the mortality risk approaches that of an age-matched reference population after this interval \[[@CR32], [@CR35]\].

Patients and methods {#Sec2}
====================

A total of 308 patients who were treated for trochanteric femoral fractures between 1992 and 2005 with a minimum age of 60 years were enrolled in this study. Seventeen patients with pathologic fractures due to metastases were excluded. Information about survival after 1 year could be achieved from 283 of the 291 patients.

Two hundred and seventeen patients (76.7%) were female. The mean age at the time of surgery was 80.5 (±9) years ranging from 60 to 98 years. Women (82 ± 8 years) of our cohort were significantly older than men (75.5 ± 11 years; *P* \< 0.01).

The fracture type was classified according to the System of the Orthopedic Trauma Association (AO/OTA) \[[@CR24]\]. Pertrochanteric two part fractures are classified as A1-type, multi-part fractures as A2-type and reversed oblique intertrochanteric fractures as A3-type fractures. While all A1-type fractures are considered to be stable, most of the A2 and all A3 type fractures are unstable \[[@CR19]\]. The distribution of the fracture types within the treatment groups is displayed in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Distribution of the surgical treatment depending on the fracture type. The dynamic hip screw (DHS) was mostly used in more stable fractures, while the proximal femoral nail (PFN) was mainly used in A3-type fractures (*X*² = 22.4, *P* \< 0.001)

A total of 109 patients (38.5%) were treated with a "dynamic hip screw" (DHS by Synthes^®^). Within this group there were mainly stable fractures type A1 (52%) or A2 (44%; Table [1](#Tab1){ref-type="table"}); 132 patients (46.6%) were treated with primary arthroplasty, 117 with a total hip replacement (THR) and 15 with a bipolar hemiarthroplasty (HA). Since 2000 PFN (Synthes^®^) was used in 42 of the 100 cases, mainly for unstable fractures in patients without advanced osteoarthritis. As demonstrated in Table [1](#Tab1){ref-type="table"}, these patients were younger and more frequently male (*P* \< 0.05). Table 1Description of the baseline variables within the treatment groupsArthroplastyDHSPFNAge (years)83 ± 779 ± 975 ± 12Number of patients13210942Gender Female115 (87%)80 (73%)26 (62%) Male17 (13%)29 (27%)16 (38%)≥4 comorbidities63 (48%)56 (51%)17 (41%)Fracture type A137 (28%)57 (52%)7 (17%) A282 (63%)48 (44%)29 (69%) A312 (9%)5 (4%)6 (14%)Year of injury 1992--1999111 (84%)72 (66%)0 (0%) 2000--200521 (16%)37 (34%)42 (100%)

Outcome variables {#Sec3}
-----------------

Primary outcome variable was the 1-year mortality risk (Table [2](#Tab2){ref-type="table"}). Furthermore, the occurrence of complications which led to further interventions was analyzed in multiple regression analysis. These were dislocation of the hip, non-union of the fracture, cutting out of the hip screw, infections, thrombosis and hematoma. The Merle d\'Aubigne test (0 to 18 points) was used to assess the patients \[[@CR10]\]. We further questioned whether the patients returned to their preoperative status (e.g. living at home).Table 2The distribution of fracture type and treatment and its specific mortality1992--19992000--20051992--2005*n*DeathMortality (%)*n*DeathMortality (%)*n*DeathMortality (%)A1711926.829413.81002323.0 THR34926.50034926.5 HA003133.33133.3 DHS371027.019315.8561323.2 PFN000.0700.0700.0A2952829.5661319.71614125.5 THR652436.96233.3712636.6 HA001218.31218.3 DHS30413.318211.148612.5 PFN0030826.730826.7A317635.35120.022731.8 THR12541.60012541.6 HA000000 DHS5120.0005120.0 PFN005120.05120.0All fractures1835329.01001818.02837125.1 THR1113834.26233.31174034.2 HA0015213.315213.3 DHS721520.837513.51092018.4 PFN0042921.442921.4*THR* total hip replacement, *HA* hemiarthroplasty, *PFN* proximal femoral nail, *DHS* dynamic hip screw

Surgical technique {#Sec4}
------------------

The proximal femoral nail (PFN by Synthes^®^-Switzerland) or the dynamic hip screw (DHS by Synthes^®^-Switzerland) was used according to the manufacturer's instructions. For closed reduction the patients were positioned supine on a fracture table. Only 135° four hole-DHS plates without additional trochanteric stabilizing plates or tension band wires were used in this series.

For hemiarthroplasty a standard cemented stem (Weller, Aesculap, Germany) and a bipolar head (DePuy, Leeds, England) were used. All femoral stems were cemented using the modern 3D generation cementing technique \[[@CR2]\]. In cases of total hip replacement, a polyethylene cup (Aesculap^®^, Germany) was cemented in the same manner (Fig. [3](#Fig3){ref-type="fig"}).

Statistics {#Sec5}
----------

First we performed univariate analysis of independent variables (age, sex, treatment, preoperative risk factors, etc.) and mortality using Fischer's exact test for qualitative variables and ANOVA for quantitative variables. The homogeneity of variance was checked by Levene test. All tests were two-sided and a *P* ≤ 0.05 was considered to be significant.

The influence of treatment on mortality was checked by a multiple logistic regression model adjusted for the presence of preoperative comorbidities (four or more vs. up to three), fracture classification, age, gender, complications requiring revision surgery and year of surgery.

We used RR additional to OR because the more frequent the outcomes becomes, the more the odds ratio will overestimate the risk ratio when it is more than 1 or underestimate the risk ratio when it is less than 1 \[[@CR34]\]. Odds ratios (OR) were transferred to relative risks (RR) according to the method of Zhang et al. \[[@CR34]\] with the formula: RR = OR/\[(1 − *P*~0~) + (*P*~0~ × OR)\], where *P*~0~ is the incidence of the outcome in the nonexposed group (reference category), and OR the odds ratio given by the multiple analysis. A RR \< 1 refers to a factor category that is mitigating (decreasing) the risk of the outcome (e.g. dying) when present, an RR \> 1 refers to a factor category that is increasing that risk when present compared with the reference category.

All analyses were conducted with the SPSS statistic software for Windows 12.0 (SPSS, Chicago, IL, USA).

Results {#Sec6}
=======

Surgery {#Sec7}
-------

Eighty-five percent of our patients were operated within 1 day after admission. In the other cases, operation was delayed to improve the preoperative condition of the patient, e.g. by transfusion or change of medication. This was independent of the treatment groups (*P* = 0.307). Mean blood loss and operating time differed significantly depending on the type of operation. The mean blood loss for arthroplasty (1,050 ± 700 ml) was significantly higher than for fixation with a DHS (409 ± 360 ml) or PFN (332 ± 277 ml; *P* \< 0.001). Implantation of a hip replacement took a mean of 115 ± 36 min, that of a DHS 73 ± 38 min and of a PFN 84 ± 32 min (*P* \< 0.001) including time for closed reduction on the extension rag. Fracture classification significantly influenced operating time if an arthroplasty was performed. It was 100 ± 24 min for A.1, 121 ± 39 min for A.2 and 127 ± 26 min for A.3-fractures (*P* = 0.012). The blood loss was similarly influenced (800 ± 460 ml for A.1, 1,200 ± 800 ml for A.2, 900 ± 500 ml for A.3 fractures; *P* = 0.019)

Mortality {#Sec8}
---------

Six patients (2.1%) died during hospitalization, 25 (8.9%) within 90 days. These were patients with considerable preoperative risk factors; 71 patients (25.2%) died within 1 year (Table [2](#Tab2){ref-type="table"}).

Influence of gender and age {#Sec9}
---------------------------

As demonstrated in Fig. [2](#Fig2){ref-type="fig"}, survival was correlated to age and gender; 34.8% of the male and 24.9% of our female patients dies within the first year (relative risk 0.34, *P* = 0.004; Table [4](#Tab4){ref-type="table"}). Not considering the different treatment groups patients over the age of 80 years had an increased mortality risk (*P* = 0.004). Fig. 2Influence of age and gender. Independent of the treatment and fracture type the mortality risk was significantly influenced by age for both genders (*P* = 0.018 for men, *P* = 0.002 for women). After multivariate analysis, the risk to die was significantly lower for woman (relative risk 0.34, *P* = 0.004) and higher for patients over the age of 90 years (relative risk 3.61; *P* = 0.009)

Influence of comorbidities {#Sec10}
--------------------------

The comorbidities and their prevalence are shown in Table [3](#Tab3){ref-type="table"}. Of the single comorbidities only cardiac arrhythmia and cerebral diseases (*P* = 0.04) showed a significant influence on mortality. Logistic regression analysis demonstrated that four or more comorbidities increased the risk to die by 78% (relative risk 1.78, *P* = 0.009; Table [4](#Tab4){ref-type="table"}). Forty-eight percent of our patients had four or more comorbidities and showed a mortality risk of 33.3% compared with 17.4% if they had less than four (*P* = 0.032 in χ^2^-test). Table 3The prevalence and relative risks of the most common comorbiditiesComorbidity*nP*o*P* (Fisher's exact)RRORCI 95%*P* (log. reg.)Heart attack1240.3400.431.121.190.56--2.140.69Cardiac arrhythmia470.3540.01\*\*1.101.161.02--2.430.04\*Cardiac insufficiency1110.3040.821.441.790.67--3.180.55Hypertonus1540.2681.000.980.970.55--1.730.92Pulmonary diseases660.2880.731.071.10.57--2.160.77Anemia470.3190.351.261.430.69--2.960.33Renal insufficiency470.2611.000.850.810.38--1.750.60Cerebral diseases1270.3360.301.421.811.02--3.220.04\*Diabetes mellitus920.3260.281.241.410.79--2.520.25Metabolic diseases300.2330.820.750.70.27--1.800.46Alcohol/nicotine/other drugs290.3210.351.511.980.79--4.990.14Gastrointestinal disease420.2440.310.760.710.32--1.640.43Others570.3040.851.011.010.51--2.030.96Relative risks (RR) are computed from odds ratios (OR) by the following formula: RR = OR/\[(1 -- *P*~0~) + (*P*~0~ × OR)\]*P*~0~ is the proportion of patients with the respective disease dying within 1-year after proximal femoral fractureRR \< 1.0 represents a minor risk of mortality; RR \> 1.0 represents a major risk of mortality compared with patients without this criteria; \* *P* ≤ 0.05; \*\* *P* ≤ 0.01Table 4Multiple logistic regressions analysis of a 1-year mortality after proximal femoral fractures of elderly patientsDescription of the analysisInfluence of interaction of kind of treatment and fracture classification after adjusting age, gender, comorbidities, revision surgery and date of surgeryOdds ratio95% CI*P*Relative riskInfluence: interaction of kind of treatment and fracture classification^e^ A1\*PFN0.0000.0000.9990.00 A1\*DHS0.6380.228--1.7870.3920.71 A2\*TEP1.3910.566--3.4200.4721.25 A2\*PFN1.1240.272--4.6470.8721.08 A2\*DHS0.3720.112--1.2370.1070.46 A3\*TEP2.1200.502--8.9540.3071.59 A3\*PFN1.0170.087--11.8330.9891.01 A3\*DHS1.0930.096--12.3870.9431.06Influence: age category^c^ 70--79 years1.2310.334--4.5320.7551.19 80--89 years2.7980.785--9.9700.1122.23 \>90 years6.3811.603--25.4030.0093.61Influence: gender^d^ Female gender0.3380.161--0.7080.0040.44Influence: comorbidities complications and year of surgery ≥4 comorbidities2.2381.219--4.1090.0091.78 Revision surgery1.1950.448--3.1840.7221.13 Surgery after 20000.7750.343--1.7520.5410.83Relative risks (RR) are computed from OR (odds ratio) by the following formula:RR = OR/\[(1 − *P*~0~) + (*P*~0~ × OR)\]*P*~0~ is the proportion of patients in the respective reference category dying within 1-year after proximal femoral fractureRR \< 1.0 represents a minor risk of mortality; RR \> 1.0 represents a major risk of mortality compared with patients without this criteriaNumber of cases in all models: 282^a^Reference: TEP^b^Reference: A1^c^Reference: \<70 years^d^Reference: male gender^e^Reference: A1\*TEP

Influence of fracture-classification and treatment {#Sec11}
--------------------------------------------------

Only pertrochanteric fractures were enrolled in this study and sorted according to the AO/OTA classification (Fig. [1](#Fig1){ref-type="fig"}). While the mortality did not differ between A1- (23.0%) and A2-type fractures (25.5%), it was higher in A3-type fractures (31.8%; Table [2](#Tab2){ref-type="table"}). As this fracture type affected only 7% of our patients, it did not significantly influence the mortality risk (*P* = 0.42).

About 18.4% of the patients who received a dynamic hip screw, 21.4% of those who received a proximal femoral nail and 33% in the arthroplasty groups (THR and HA) died within 1 year (*P* = 0.011). As the indication for surgery was not randomized but decided on fracture classification and clinical status we attempted to reduce these influences in a multiple logistic regression analysis (Table [4](#Tab4){ref-type="table"}). All potential influencing factors as gender, age, fracture type and amount of comorbidities were taken into account. If categorical variables were used to evaluate the interaction between fracture classification and treatment, we could not find a statistical influence of surgical treatment on mortality (Table [4](#Tab4){ref-type="table"}). The relative risk to die was decreased for A.1- and A.2-type fractures, treated with a DHS, but this did not reach significance levels. As only seven patients with a A.1-type fracture were treated with a PFN (and all of them survived), no sensible statistical analysis can be done for this category. As all devices showed good results for this kind of fracture, the decision should be based on other parameters for A.1-type fractures.

Because our treatment regime was changed in the beginning of 2000 (introduction of the PFN, new bipolar hemiarthroplasty instead of total hip arthroplasty; Table [2](#Tab2){ref-type="table"}), we implicated the time of surgery in our analysis. Since then the 1-year mortality after arthroplasty decreased from 34.2 to 19% (*P* = 0.26, Fisher's exact test). Although over all mortality decreased from 29 to 18%, no influence of time of surgery on the mortality risk could be found using multivariate regression analysis (*P* = 0.54; Table [4](#Tab4){ref-type="table"}).

Influence of complications {#Sec12}
--------------------------

The only postoperative complication which influenced the survival rate was postoperative pneumonia. It occurred in 13 cases independent of the treatment groups (*P* = 0.26). Six of the patients died within 1 year (*P* = 0.048).

The DHS had a revision rate of 8.1%, while the PFN needed reoperations in nine cases (22.5%). The main reason was cutting out of the screw in the osteoporotic bone and postoperative hematoma. Due to cutting out and fixation failure secondary hip arthroplasty was performed after failed internal fixation ten times. It happened six times (5.4%) after a DHS and four times (9.8%) after a PFN.

The main complication after arthroplasty was dislocation, which occurred in 16 patients (12%). It did not occur with bipolar hemiarthroplasty. While dislocation was only a minor problem in A1-type fractures (7%), it occurred in ten A2-type (12%) and two of the nine A3-type fractures (22%). Patients were usually treated by closed reduction and physiotherapy and it did not influence mortality (*P* = 0.78).

Rehabilitation {#Sec13}
--------------

The mean hospital stay was 18 days and did not differ significantly between the three treatment groups (*P* = 0.7). It prolonged to a mean of 30 days if a reoperation became necessary (*P* = 0.003). Patients who were ambulatory before the injury could walk with a walker or sticks at time of discharge; 80% of the surviving patients who were independent before the injury regained their preoperative status after 1 year. Since the year 2000 patients were encountered to a prospective registry. The mean Merle d'Aubigné score (0--18 points) for the surviving 78 patients was 13.8 ± 2.5. No significant differences could be found between the three treatment groups (*P* = 0.122).

Discussion {#Sec14}
==========

While primary arthroplasty is a standard procedure for femoral neck fractures, little experience exists for trochanteric fractures \[[@CR4], [@CR5], [@CR9], [@CR28]\]. They were primarily used as a salvage procedure after failed internal fixation \[[@CR12], [@CR15], [@CR21], [@CR23], [@CR31]\]. Most authors implanted special calcar replacement devices, which are expensive and require the removal of large portions of the proximal femur \[[@CR3], [@CR8], [@CR13], [@CR28]\]. We used a standard cemented stem and either a standard cemented cup or a bipolar head since the 1970s in our hospital. As it proved superior to former methods of internal fixation even for pertrochanteric fractures it was the treatment of choice since 1992 \[[@CR26]\]. From the year 2000 on hemiarthroplasty was routinely used instead of total hip arthroplasty and the proximal femoral nail was introduced for patients without advanced osteoarthritis.

The ideal treatment for intertrochanteric fractures is still under debate as none of the existing osteosynthetic devices could prove its superiority in former studies \[[@CR16], [@CR25], [@CR29], [@CR30]\]. The most frequent problem in elderly patients who usually are not able to walk without weight bearing was a cutting out of the hip screw which occurred in 4 to 20% of the reported cases \[[@CR4], [@CR6]\]. In our series this complication was only seen in comminuted fractures (A2 and A3 type). Thus, 10 times (6.2% of the internal fixation devices) a secondary hemiarthroplasty was performed. Immediate full weight bearing regardless of bone quality is an advantage of primary cemented arthroplasty. In our hospital, all patients are encouraged to stand up the day after surgery. Dislocation was the major complication in patients treated with a total hip replacement after comminuted pertrochanteric fractures. This high dislocation rate is rarely seen after primary hip arthroplasty but well known even for femoral neck fractures \[[@CR22]\] or revision surgery \[[@CR33]\] and can be attributed to insufficient muscular stability. Fractures of the greater or lesser trochanter might exaggerate this problem. The use of bipolar arthroplasty instead of total hip replacements can reduce this complication to an acceptable rate \[[@CR11], [@CR28]\]. Since we use total hip arthroplasty only in patients of good physical shape with severe osteoarthritis we did not see any dislocations.

Ambulatory levels and clinical scores are considerable affected by the preoperative status. Since clinical examination usually cannot be obtained for all patients, reliable comparison is difficult. Some authors use telephone interviews \[[@CR4]\] or report about less than 50% of their patients for a 1-year follow-up \[[@CR10]\]. In both cases it can be assumed that patients with bad functional results are not regularly included. We could also examine only 78% of the last 100 patients clinically and therefore do not want to overemphasize these findings. Instead we chose the 1-year mortality risk as the primary outcome parameter as it could be obtained for all patients and is related to the postoperative ambulatory status as well as to the operative trauma \[[@CR14]\]. In a previous study with more than 500 fractures, we could demonstrate that patients who regained their independency and were able to attend a rehabilitation institution had a significantly lower mortality risk \[[@CR7]\], which was further supported in this study.

Mortality was significantly influenced by patient related factors such as gender, age and comorbidities but not by the fracture type. In accordance with our former studies and other authors \[[@CR7], [@CR17], [@CR20], [@CR26]\] few single comorbidity influenced the mortality risk whereas the sum of four or more comorbidities increased the risk to die by approximately 78% (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). Patients who received a PFN or DHS were significantly younger and healthier than those in the arthroplasty group. These influences were reduced by multivariate regression analysis (Table [4](#Tab4){ref-type="table"}). Furthermore, the interaction of fracture type and treatment was taken into account. Considering these influences, no significant influence of one of the three treatment groups on the mortality risk could be found. In studies that only use internal fixation devices mortality risks comparable with our over all mortality were found \[[@CR27]\], thus---in accordance with other authors \[[@CR3], [@CR13]\]---we think that cemented hemiarthroplasty is an alternative to internal fixation in elder patients especially as our revision rate was significantly lower for arthroplasty compared with internal fixation.

Only Chan et al. \[[@CR4]\] published a study about the use of a standard hemiarthoplasty for the treatment of displaced intertrochanteric fractures. In their small group of 54 patients they found a mortality rate of 31.5% within 1 year which did not differ from comparable age-matched studies. The walking ability of their patients was favorable compared with other studies with internal fixation. We agree that immediate full weight bearing, which can be achieved after cemented arthroplasty, is crucial for these patients.

Haentjens et al. compared 37 patients who received a calcar replacement device with 42 patients of a retrospective group, who were treated by internal fixation and found an advantage in functional outcome \[[@CR10]\]. Although the mortality rate could not be decreased, early walking with full weight bearing reduced the incidence of pressure sores, pulmonary infection and atelectasis. Kim et al. \[[@CR18]\] who compared a calcar replacement prosthesis with intramedullary fixation in a prospective study in two small groups of 29 patients could not find a significant difference concerning the functional outcomes, but the cut-out rate of the hip screw was 7% in their patients.

Up to now a clear indication of arthroplasty in the treatment of pertrochanteric fractures does not exist. Although operation time and blood loss are higher no significant difference concerning the mortality rate between primary arthroplasty and internal fixation could be found, but the revision rate in the arthroplasty group was significantly smaller especially since we use bipolar hemiarthroplasty instead of a total hip replacement. If the cemented arthroplasty has been performed accurately, there is very little concern about weight bearing. Furthermore, primary arthroplasty eliminates the possibility for malunion, cut-out of the hip screw and avascular necrosis of the femoral head. But primary arthroplasty is a technically challenging procedure. All lose fragments including the greater and the lesser trochanter have to be attached with cerclage wires before cementing the stem to prevent extrusion (Fig. [3](#Fig3){ref-type="fig"}) and especially in utterly comminuted fractures orientation of the rotation and leg length can be demanding. Fig. 3Examples of treatment of A2-type fractures with a hemiendoprosthesis and tension band wires. Depending on the fracture type different ways of fixating the trochanteric region with wires were used. In the case of a calcar fragment reaching distal to the lesser trochanter a temporary reduction with a cerclage wire or reduction bone clamp was used before reaming. Final fixation of the greater trochanter was performed after reduction of the hip with cerclages or a tension band

The DHS is not suitable for reverse oblique and comminuted fractures \[[@CR19], [@CR30]\] but for stable fractures it seems to be advantageous to short femoral nails regarding reoperation rate and fracture fixation failure in the literature \[[@CR16], [@CR29]\]. We further support the recommendation that the DHS should be used for stable A1- and A2.1-type fractures while an intramedullary device is advantageous for unstable fractures. Primary cemented arthroplasty is a viable option for the treatment of trochanteric fractures in a selected group of previously independent mobile patients especially if osteoporosis would prevent full weight bearing or osteoarthritis would make further operations necessary. The routine use of total hip arthroplasty was abandoned in our hospital as the luxation rate was higher than after hemiarthroplasty. It is still used as salvage procedure after failed internal fixation in elder patients with bad bone quality.
